Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
09/2005
09/01/2005CA2555342A1 Polypeptides for inducing a protective immune response against staphylococcus aureus
09/01/2005CA2555340A1 Gene disruptions, compositions and methods relating thereto
09/01/2005CA2555236A1 Methods of modulating cytokine activity; related reagents
09/01/2005CA2555208A1 Nucleic acid molecules encoding novel murine low-voltage activated calcium channel proteins, designated-alpha 1h, encoded proteins and methods of use thereof
08/2005
08/31/2005EP1568777A1 Deletion mutants from Neisseria glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
08/31/2005EP1568775A1 Cancer-associated gene
08/31/2005EP1568772A2 Human growth hormone variants
08/31/2005EP1568771A2 Human growth hormone variants
08/31/2005EP1568770A2 Pharmaceutical use of compounds which bind to a mammalian "trace amine" receptor
08/31/2005EP1568768A1 PROTEIN BINDING TO Akt2
08/31/2005EP1568767A2 Dna fragments of lav genes
08/31/2005EP1568709A2 Purification of fibrinogen
08/31/2005EP1568708A2 Methods and medical uses of nucleic acids encoding a TRAF inhibitor
08/31/2005EP1568707A1 Antihypertensive peptides from casein hydrolysates
08/31/2005EP1568378A1 Passive immunization against clostridium difficile disease
08/31/2005EP1568376A2 Use of alpha-1 antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds
08/31/2005EP1568373A2 Inducing cellular immune responses to HER2/neu using peptide and nucleic acid compositions
08/31/2005EP1567862A2 Compositions and methods for the reversible capture of biomolecules
08/31/2005EP1567857A2 Method for screening modulators of mitochondrial functioning
08/31/2005EP1567659A2 Method for continuous, automated blending of solutions from acids and bases
08/31/2005EP1567657A1 Process for purifying a fermentation-derived product
08/31/2005EP1567651A2 Production of pharmaceutically active proteins in sprouted seedlings
08/31/2005EP1567647A1 Soluble notch-based substrates for gamma secretase and methods and compositions for using same
08/31/2005EP1567644A2 Tissue specific genes and gene clusters
08/31/2005EP1567641A2 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
08/31/2005EP1567640A2 Pokeweed antiviral protein polypeptides with antiviral activity
08/31/2005EP1567556A2 Recombinant immunotoxin and use in treating tumors
08/31/2005EP1567554A1 Icam-4 binding sites
08/31/2005EP1567553A2 Complexes of receptors
08/31/2005EP1567552A2 Novel ifngamma-like polypeptides
08/31/2005EP1567550A2 Peptide conjugate useful for cell nucleus molecular imaging and tumor therapy
08/31/2005EP1567549A1 Methods for the production of methionine
08/31/2005EP1567548A1 Engineering redox proteins
08/31/2005EP1567547A2 Hepatisis c virus nonstructural protein 4a (ns4a) is an enhancer element
08/31/2005EP1567545A2 Peptides, antibodies thereto, and their use in the treatment of central nervous system damage
08/31/2005EP1567544A2 Use of hmgb polypeptides for increasing immune responses
08/31/2005EP1567542A2 Novel inhibin-related multiple antigenic peptide compositions that enhance production performance in avians
08/31/2005EP1567541A2 Rationally designed antibodies
08/31/2005EP1567190A2 A hepatitis c virus codon optimized non-structural ns3/4a fusion gene
08/31/2005EP1567189A1 Malaria vaccine
08/31/2005EP1567188A2 Modified viral particles with immunogenic properties and reduced lipid content useful for treating and preventing infectious diseases
08/31/2005EP1567178A1 Modulators of receptors for parathyrois hormone and parathyroid hormone-related protein
08/31/2005EP1567045A2 Methods for diagnosing the presence or stage of cancer
08/31/2005EP1566999A2 Production of increased oil and protein in plants by the disruption of the phenylpropanoid pathway
08/31/2005EP1463532A4 Dose response-based methods for identifying receptors having alterations in signaling
08/31/2005EP1395612B1 Modified recombinase
08/31/2005EP1368579A4 Synthetic molecular spring device
08/31/2005EP1328811B1 Hcv mosaic antigen composition
08/31/2005EP1263773A4 Oligonucleotide analogues, methods of synthesis and methods of use
08/31/2005EP1173475B1 Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients
08/31/2005EP1172372B1 Process for producing subunit peptide origintaing in polymer protein
08/31/2005EP1095020B1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them
08/31/2005EP1078064B1 Compounds from moraxella catarrhalis
08/31/2005EP1073721B1 Efficient purification of adenovirus
08/31/2005EP0996731B1 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses
08/31/2005EP0941333B1 Immunogenic detoxified mutant e. coli lt-a toxin
08/31/2005EP0786002B1 Intracellular isoform of the interleukin-1 receptor antagonist
08/31/2005EP0721345B1 Prostatic cancer vaccine
08/31/2005CN1662816A Method for identifying and extracting endotoxin
08/31/2005CN1662664A Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions
08/31/2005CN1662663A DNA enzyme to inhibit plasminogen activator inhibitor-1
08/31/2005CN1662657A Low-cost production of peptides
08/31/2005CN1662555A Chimeric antagonist ANTH1
08/31/2005CN1662554A Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
08/31/2005CN1662553A Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions
08/31/2005CN1662550A Peptides from the e2, e6 and e7 proteins of human papillomaviruses 16 and 18 for detecting and/or diagnosing cervical and other cancers
08/31/2005CN1662262A Decoys for treating and/or preventing Th2 cytokine-related allergic diseases, GATA3 mutant proteins and pharmaceutical compositions comprising the decoys and the proteins
08/31/2005CN1662261A Increased delivery of a nucleic acid construct in vivo by the poly-L-glutamate (
08/31/2005CN1662254A ALCAM and ALCAM modulators
08/31/2005CN1662253A Packaged virus-like particles for use as adjuvants: method of preparation and use
08/31/2005CN1662142A Oil body associated protein compositions, methods of and use thereof for reducing the risk of cardiovascular disease
08/31/2005CN1661109A Novel targets for obesity from skeletal muscle
08/31/2005CN1661036A Method for preparing interferon of white blood cells of dogs
08/31/2005CN1661035A Method for preparing leukocyte interferon of pig
08/31/2005CN1661019A Method for producing recombined endothelium chalone in bacillus colis and application
08/31/2005CN1661014A Novel method to isolate mutants and to clone the complementing gene
08/31/2005CN1661013A Protein interactive with coat protein of tomato mosaic virus, its coded genes and application
08/31/2005CN1661012A Miniaturized polypeptide of anti EB Virus tumour, application and preparation method
08/31/2005CN1661011A Derivative growth factor of recombined human blood platelet, coded genes and expression method
08/31/2005CN1661009A Product of transegenic plant for expressing coat protein of human rotavirus and application for preventing infant diarrhea
08/31/2005CN1660913A Immunoassays for anti-HCV antibodies
08/31/2005CN1660911A Connective tissue growth factor fragments and methods and uses thereof
08/31/2005CN1660903A Method for retrieving albumin from deposited components I, II, III, IV
08/31/2005CN1660902A Segregative technique for purifying stimulating factor of recombined human beta lymphocyte
08/31/2005CN1660901A Method for preparing solution of keratin
08/31/2005CN1660900A CUDR as biomarker for cancer progression and therapeutic response
08/31/2005CN1660899A GP thymosin alpha 1 and preparation method
08/31/2005CN1660898A Method for retrieving albumin form constituent deposition 123
08/31/2005CN1660897A Method for extracting and purifying glycoprotein shuck
08/31/2005CN1660896A Abstraction method for preparing lactic acid streptocin through method of resin
08/31/2005CN1660895A Synthesized polypeptide and application
08/31/2005CN1660886A Process for crosslinking proteins with a ketose containing 3 to 5 carbon atoms
08/31/2005CN1660426A Methods for inhibiting brain tumor growth
08/31/2005CN1217190C Modulation of smrl-nep interactions in cns disorders giving rise to mental disorders
08/31/2005CN1216995C DNA Sequence Coding for protein of A. thaliana having delta-5,7 terol, delta-7 reductase activity, delta T-red protein, production process strains of transformed yeasts uses
08/31/2005CN1216992C Immunomodulators
08/31/2005CN1216991C Human guanosine monophophate reductase and its coding sequence and preparation method
08/31/2005CN1216986C Method for expressing modified human alpha antitrypsin gene in sheep's mammar gland
08/31/2005CN1216913C Human interleukin-17 receptor sampling molecule fusion protein and coding gene and expression cell line
08/31/2005CN1216912C Human interleukin-17 receptor-like protein, its coding gene and use thereof
1 ... 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 ... 2916